AIDS related changes in pattern of sexually transmitted disease (STD) in an STD clinic in Copenhagen.

Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

AIDS related changes in pattern of sexually transmitted disease (STD) in an STD clinic in Copenhagen.

Genitourin Med. 1988 Aug;64(4):270-2. Unique Identifier : AIDSLINE MED/89006678
Petersen CS; Sondergaard J; Wantzin GL; Department of Dermatovenereology, Bispebjerg Hospital,; Copenhagen, Denmark.

Abstract: Testing for antibodies against human immunodeficiency virus (HIV) was introduced in 1984 in this major sexually transmitted disease (STD) clinic in Copenhagen, which is attended by about 10,000 new patients each year. From 1984 to 1987 the proportion of patients examined for antibodies to HIV rose from 6% to 32%. The overall incidence of HIV antibody positivity decreased from 30% in 1984 to 3% in 1987, the combined result of decreased positivity in high risk patients tested and increased screening in low risk patients. HIV antibody positivity has been confined largely to homosexual men and drug addicts. Since 1985, however, 21 out of 2623 (0.8%) heterosexuals who were not drug addicts were found to be HIV antibody positive. During 1984-6 the incidence of STDs most often encountered in high risk groups (syphilis and gonorrhoea) decreased by 64% and 41% respectively, whereas the incidence of diseases most often diagnosed in low risk groups (condylomata acuminata and genital herpes) increased by 70% and 34% respectively in the same period. The addition of HIV infection to the list of STDs requires the allocation of more resources to the STD clinics to enable these clinics to handle this new problem. Screening for all patients attending an STD clinic for antibodies to HIV must be considered, and in our area it would be cost effective.

Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY Chlamydia Infections/EPIDEMIOLOGY Condylomata Acuminata/EPIDEMIOLOGY Denmark Female Gonorrhea/EPIDEMIOLOGY Herpes Genitalis/EPIDEMIOLOGY Human HIV Seropositivity/EPIDEMIOLOGY Male Outpatient Clinics, Hospital Sexually Transmitted Diseases/*EPIDEMIOLOGY Syphilis/EPIDEMIOLOGY JOURNAL ARTICLE

890130
M8910477

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .